BIOVIE
BioVie is pioneering an innovative therapeutic approach targeting ascites due to liver cirrhosis. Ascites, or the accumulation of fluid in the abdomen, is the most common complication of cirrhosis due to NASH (non-alcoholic steatohepatitis), alcoholic liver disease and/or hepatitis C. Ascites affects about 100,000 Americans and many times more worldwide, and contributes substantially to mortality. Our therapy BIV201 is based on a drug that is not yet available in the US but is approved in about... 50 countries to treat related complications of liver cirrhosis. The Company, formerly knows as NanoAntibiotics, Inc., recently acquired LAT Pharma LLC. This merger provided our lead development program, BIV201. Following a pre-investigational new drug meeting (“pre-IND”) with the FDA in early 2016, the Company is now assembling its IND package, and may commence a US clinical trial as early as 2017.
BIOVIE
Industry:
Biotechnology Health Care Innovation Management Therapeutics Wellness
Founded:
2013-01-01
Address:
Beverly, Massachusetts, United States
Country:
United States
Website Url:
http://www.biovieinc.com
Total Employee:
1+
Status:
Active
Contact:
(312)283-5793
Email Addresses:
[email protected]
Total Funding:
47.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS GoDaddy Bizo
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Nascent Biotech
Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic antibodies.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-18 | LAT Pharma | LAT Pharma acquired by BioVie | N/A |
Investors List
Avenue Capital Group
Avenue Capital Group investment in Post-IPO Debt - BioVie
Key Employee Changes
Official Site Inspections
http://www.biovieinc.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioVie"
BioVie Pharma | New solutions for Alzheimer's, …
This website contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties, and assumptions that could cause BioVie’s actual …See details»
BioVie Inc. (BIVI) Company Profile & Facts - Yahoo Finance
See the company profile for BioVie Inc. (BIVI) including business summary, industry/sector …See details»
BioVie Inc. - LinkedIn
BioVie Inc. | 2,222 followers on LinkedIn. Developing innovative therapies for the treatment of …See details»
BioVie Inc. (BIVI) Company Profile & Overview - Stock Analysis
Nov 22, 2024 680 West Nye Lane, Suite 204 Carson City, Nevada 89703 United StatesSee details»
BioVie - Crunchbase Company Profile & Funding
BioVie is a purpose-driven company. BioVie develops new solutions to help people live …See details»
BioVie - Overview, News & Similar companies | ZoomInfo.com
BioVie contact info: Phone number: (312) 283-5793 Website: www.biovieinc.com What does …See details»
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
Mar 11, 2024 Recently completed financing provides sufficient funds for near-term …See details»
BioVie Inc. Announces Closing of Public Offering of Common Stock
SANTA MONICA, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) …See details»
BioVie Company Profile - Office Locations, Competitors, Revenue …
Oct 11, 2024 BioVie (formerly knows as NanoAntibiotics) is a therapeutical company …See details»
Investors Information - BioVie Pharma
Investors can find information relating to BioVie, including Presentations, Press Releases, SEC …See details»
BioVie Inc. - Cruelty Free Investing
Company Website: https://www.biovieinc.com Contact: [email protected] ©2024 …See details»
BioVie Acquires Biopharma Assets from Privately Held NeurMedix
Apr 27, 2021 Includes Pivotal Phase 3 Alzheimer’s Asset NE3107. Cuong V. Do Named CEO …See details»
Innovations - BioVie Pharma
A Purpose-Based Company Through innovation, collaboration, and people- centered science, …See details»
BioVie Commences Patient Screening in Phase 2 Clinical Trial
Mar 9, 2021 --BioVie Inc., a clinical-stage company developing innovative drug therapies for …See details»
BioVie Inc. (BIVI) Stock Price, News, Quote & History - Yahoo Finance
Find the latest BioVie Inc. (BIVI) stock quote, history, news and other vital information to help …See details»
Press Releases | Investors Info - BioVie Pharma
Press Releases featuring BioVie from publications and organizations, including Bloomberg, …See details»
Presentations | Investors Info - BioVie Pharma
Nov 1, 2023 Presentations | BioVie Company Overview, BioVie KOL Webinar, American …See details»
BioVie Announces Closing of Acquisition of BioPharma Assets
SANTA MONICA, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) …See details»
BioVie Acquires Biopharma Assets from Privately Held
Apr 27, 2021 Includes Pivotal Phase 3 Alzheimer’s Asset NE3107 Cuong V. Do Named CEO …See details»
BioVie Inc. (BIVI) Latest Stock News & Headlines - Yahoo Finance
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded. CARSON CITY, Nev., …See details»